Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46]
- RabMAb
- Recombinant
- 20ul selling size
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal SQSTM1 / p62 antibody. Suitable for I-ELISA, ICC/IF, WB and reacts with Synthetic peptide - Human, Human samples.
View Alternative Names
ORCA, OSIL, SQSTM1, Sequestosome-1, EBI3-associated protein of 60 kDa, Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa, Ubiquitin-binding protein p62, EBIAP, p60, p62
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized HeLa(human cervical adenocarcinoma epithelial cell) untreated, HeLa treated with TNF alpha (100 ng/ml) and IKK-16(1uM) for 4 hours and HeLa treated with TNF alpha (100 ng/ml), IKK-16(1uM) and Z-VAD-FM(20uM) for 4 hours cells labelling SQSTM1 / p62 with ab325681 at 1/50 (10.24 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).
Confocal image showing increased cytoplasmic staining in HeLa cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel B). No staining was observed in untreated HeLa cells (panel A), or HeLa cells treated with TNF alpha (100 ng/ml), IKK-16 (1uM) and Z-VAD-FM (20uM) for 4 hours (panel C). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution, followed by ab150120 Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at 1/1000 dilution (Magenta).
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
Immunofluorescent analysis of 100% methanol-fixed, 0.1% TritonX-100 permeabilized wildtype HAP1 (human chronic myelogenous leukemia near-haploid cell) untreated, wildtype HAP1 treated with TNF alpha (100 ng/ml) and IKK-16 (1µM) for 4 hours, SQSTM1 knockout HAP1 untreated and SQSTM1 knockout HAP1 treated with TNF alpha (100 ng/ml) and IKK-16 (1µM) for 4 hours labelling SQSTM1 / p62 with ab325681 at 1/50 (10.24 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 dilution (Green).
Confocal image showing increased cytoplasmic staining in wildtype HAP1 cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel B). No staining was observed in untreated wildtype HAP1 cells (panel A), untreated SQSTM1 knockout HAP1 cells (panel C), or SQSTM1 knockout HAP1 cells treated with TNF alpha (100 ng/ml) and IKK-16 (1uM) for 4 hours (panel D). The counterstain was observed in magenta. Nuclear DNA was labelled with DAPI (shown in blue). Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
ab7291 Anti-alpha Tubulin mouse monoclonal antibody was used to counterstain tubulin at 1/1000 dilution, followed by ab150120 Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) at a 1/1000 dilution (Magenta).
- WB
Lab
Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
Total protein Anti-SQSTM1 antibody [EPR18351] (ab207305) (1 : 1000).
All lanes:
Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (ab325681) at 1/1000 dilution
Lane 1:
Untreated HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HeLa treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 20 µg
Lane 3:
HeLa treated with 10ng/ml TNF alpha, 1uM IKK-16 and 20uM Z-VAD-FMK for 4 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 40 kDa,36 kDa
false
Exposure time: 10s
- WB
Lab
Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab325681 was shown to bind specifically to SQSTM1. Target of interest was observed at 40 kDa in TNF alpha and IKK-16 treated wild-type HAP1 cell lysates (lane 2) with no signal observed at this size in the SQSTM1 knockout cell line (lanes 3-4, knockout cell line ab240635).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) (1 : 200000) (36KDa).
Total protein Anti-SQSTM1 antibody [EPR18351] (ab207305) (1 : 1000).
All lanes:
Western blot - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (ab325681) at 1/1000 dilution
Lane 1:
Untreated parental HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate at 60 µg
Lane 2:
HAP1 treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 60 µg
Lane 3:
Untreated SQSTM1 knockout HAP1 whole cell lysate at 60 µg
Lane 4:
SQSTM1 knockout HAP1 treated with 10ng/ml TNF alpha and 1uM IKK-16 for 4 hours whole cell lysate at 60 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 40 kDa,36 kDa
false
Exposure time: 180s
- I-ELISA
Lab
Indirect ELISA - Anti-SQSTM1 / p62 at D329 (N-terminal) antibody [EPR29289-46] (AB325681)
Indirect ELISA analysis of ab325681 at 1000-0 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1 : 2500 dilution dilution.
Antigen : cleaved human SQSTM1 at D329 (N-terminal);Full length human SQSTM1.
Antigen concentration : 1000 ng/ml
This antibody does not cross-react with full length human SQSTM1.
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com